Related Experiment Videos
Polymyalgia rheumatica and giant cell arteritis
1Section of Geriatrics, Mayo Clinic, Rochester, Minnesota, USA.
Abstract:
PMR and GCA are related conditions that seem to represent a continuum of disease. These conditions are relatively common and seem to be mediated by a cellular inflammatory response. Increasing evidence suggests an infectious cause (or causes) precipitating this immune response in genetically susceptible individuals. Whereas previously thought to affect primarily branch vessels of the aortic arch, GCA is now thought of as a disease in which proximal aortic involvement is frequent. Despite the potential for serious, even fatal complications, overall prognosis for patients with GCA or PMR is excellent. Corticosteroids remain the standard treatment, although not curative. Whereas the ESR is a useful indicator of disease activity, other markers which may be more precise such as creative protein and Il-6 seem to offer added information about disease activity.
Insights
Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are linked inflammatory conditions. While corticosteroids are standard treatment, new markers like IL-6 offer better disease activity insights.
Area of Science:
- Rheumatology
- Immunology
- Vascular Medicine
Background:
- Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are common, related inflammatory conditions.
- These diseases are increasingly understood to involve a cellular inflammatory response, potentially triggered by infections in genetically susceptible individuals.
- Giant cell arteritis (GCA) is now recognized to frequently involve the proximal aorta, not just branch vessels.
Purpose of the Study:
- To summarize the current understanding of PMR and GCA.
- To highlight advancements in understanding the pathophysiology and scope of GCA.
- To discuss current and potential future markers for disease activity.
Main Methods:
- Review of existing literature on PMR and GCA.
- Analysis of current evidence regarding disease mechanisms and presentation.
- Evaluation of diagnostic and monitoring tools.
Main Results:
- PMR and GCA represent a disease continuum with excellent prognosis despite potential complications.
- Corticosteroids are the primary treatment but are not curative.
- Erythrocyte sedimentation rate (ESR) is a useful marker, but C-reactive protein (CRP) and Interleukin-6 (IL-6) may offer more precise disease activity information.
Conclusions:
- PMR and GCA are significant rheumatologic conditions requiring ongoing management.
- Understanding the expanded vascular involvement in GCA is crucial for patient care.
- Further research into inflammatory markers like IL-6 could improve treatment monitoring for these conditions.